1. Home
  2. ILMN vs TEM Comparison

ILMN vs TEM Comparison

Compare ILMN & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • TEM
  • Stock Information
  • Founded
  • ILMN 1998
  • TEM 2015
  • Country
  • ILMN United States
  • TEM United States
  • Employees
  • ILMN N/A
  • TEM N/A
  • Industry
  • ILMN Medical Specialities
  • TEM
  • Sector
  • ILMN Health Care
  • TEM
  • Exchange
  • ILMN Nasdaq
  • TEM NYSE
  • Market Cap
  • ILMN 13.1B
  • TEM 11.9B
  • IPO Year
  • ILMN 2000
  • TEM 2024
  • Fundamental
  • Price
  • ILMN $96.14
  • TEM $60.98
  • Analyst Decision
  • ILMN Buy
  • TEM Buy
  • Analyst Count
  • ILMN 17
  • TEM 12
  • Target Price
  • ILMN $124.35
  • TEM $65.09
  • AVG Volume (30 Days)
  • ILMN 2.4M
  • TEM 9.3M
  • Earning Date
  • ILMN 07-31-2025
  • TEM 08-05-2025
  • Dividend Yield
  • ILMN N/A
  • TEM N/A
  • EPS Growth
  • ILMN N/A
  • TEM N/A
  • EPS
  • ILMN N/A
  • TEM N/A
  • Revenue
  • ILMN $4,337,000,000.00
  • TEM $803,315,000.00
  • Revenue This Year
  • ILMN N/A
  • TEM $81.43
  • Revenue Next Year
  • ILMN $3.15
  • TEM $24.80
  • P/E Ratio
  • ILMN N/A
  • TEM N/A
  • Revenue Growth
  • ILMN N/A
  • TEM 42.93
  • 52 Week Low
  • ILMN $68.70
  • TEM $31.36
  • 52 Week High
  • ILMN $156.66
  • TEM $91.45
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 55.14
  • TEM N/A
  • Support Level
  • ILMN $95.75
  • TEM N/A
  • Resistance Level
  • ILMN $99.78
  • TEM N/A
  • Average True Range (ATR)
  • ILMN 3.15
  • TEM 0.00
  • MACD
  • ILMN -0.65
  • TEM 0.00
  • Stochastic Oscillator
  • ILMN 24.97
  • TEM 0.00

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About TEM TEMPUS AI INC

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Share on Social Networks: